公开(公告)号：US20140213601A1

公开(公告)日：2014-07-31

申请号：US14021435

申请日：2013-09-09

Applicant: ABBVIE INC.

Inventor： David A. DEGOEY ,  Pamela L. DONNER ,  Warren M. KATI ,  Charles W. HUTCHINS ,  Mark A. MATULENKO ,  Tammie K. JINKERSON ,  Ryan G. KEDDY

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

公开(公告)号：US20140213595A1

公开(公告)日：2014-07-31

申请号：US14017901

申请日：2013-09-04

Applicant: ABBVIE INC.

Inventor： David A. DEGOEY ,  Pamela L. DONNER ,  Warren M. KATI ,  Charles W. HUTCHINS ,  Allan C. KRUEGER ,  John T. RANDOLPH ,  Christopher E. MOTTER ,  Preethi KRISHNAN ,  Neeta C. MISTRY ,  Tami J. PILOT-MATIAS ,  Sachin V. PATEL ,  Xiaoyan LI ,  Todd N. SOLTWEDEL ,  Lissa T. NELSON

IPC: C07D471/04 ,  C07D239/48

CPC classification number: C07D471/04 ,  C07D239/48

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

Abstract translation: 描述了有效抑制丙型肝炎病毒（“HCV”）复制的化合物。 本发明还涉及制备这种化合物的方法，包含这些化合物的组合物，以及使用这些化合物治疗HCV感染的方法。

公开(公告)号：US20140155382A1

公开(公告)日：2014-06-05

申请号：US14087480

申请日：2013-11-22

Applicant: ABBVIE INC.

Inventor： David A. DEGOEY ,  Allan C. KRUEGER ,  Charles W. HUTCHINS ,  Warren M. KATI ,  William A. CARROLL

IPC: A61K31/55 ,  A61K31/422 ,  A61K31/4184 ,  A61K31/4178 ,  A61K45/06 ,  C07D487/04 ,  C07D417/14 ,  C07D413/12 ,  C07D403/14 ,  C07D207/16 ,  A61K31/506 ,  A61K31/4025

CPC classification number: A61K31/55 ,  A61K31/4025 ,  A61K31/4178 ,  A61K31/4184 ,  A61K31/422 ,  A61K31/506 ,  A61K38/00 ,  A61K45/06 ,  C07D205/04 ,  C07D207/16 ,  C07D207/22 ,  C07D209/52 ,  C07D211/60 ,  C07D263/06 ,  C07D277/06 ,  C07D401/14 ,  C07D403/12 ,  C07D403/14 ,  C07D405/14 ,  C07D413/12 ,  C07D413/14 ,  C07D417/14 ,  C07D487/04 ,  C07K5/06034 ,  C07K5/06043 ,  C07K5/0606 ,  C07K5/06069 ,  C07K5/06078 ,  C07K5/06139

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.